Literature DB >> 23385626

One-electron reduction of 6-hydroxydopamine quinone is essential in 6-hydroxydopamine neurotoxicity.

Monica Villa1, Patricia Muñoz, Ulises Ahumada-Castro, Irmgard Paris, Ana Jiménez, Isabel Martínez, Francisca Sevilla, Juan Segura-Aguilar.   

Abstract

6-Hydroxydamine has widely been used as neurotoxin in preclinical studies related on the neurodegenerative process of dopaminergic neurons in Parkinson's disease based on its ability to be neurotoxic as a consequence of free radical formation during its auto-oxidation to topaminequinone. We report that 50-µM 6-hydroxydopamine is not neurotoxic in RCSN-3 cells derived from substantia nigra incubated during 24 h contrasting with a significant sixfold increase in cell death (16 ± 2 %; P < 0.001) was observed in RCSN-3NQ7 cells expressing a siRNA against DT-diaphorase that silence the enzyme expression. To observe a significant cell death in RCSN-3 cells induced by 6-hydroxydopamine (24 ± 1 %; P < 0.01), we have to increase the concentration to 250 μm while a 45 ± 2 % cell death (P < 0.001) was observed at this concentration in RCSN-3NQ7 cells. The cell death induced by 6-hydroxydopamine in RCSN-3NQ7 cells was accompanied with a (i) significant increase in oxygen consumption (P < 0.01), (ii) depletion of reduced glutathione and (iii) a significant decrease in ATP level (P < 0.05) in comparison with RCSN-3 cells. In conclusion, our results suggest that one-electron reduction of 6-hydroxydopamine quinone seems to be the main reaction responsible for 6-hydroxydopamine neurotoxic effects in dopaminergic neurons and DT-diaphorase seems to play an important neuroprotective role by preventing one-electron reduction of topaminequinone.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23385626     DOI: 10.1007/s12640-013-9382-7

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  34 in total

1.  Acute L: -DOPA effect on hydroxyl radical- and DOPAC-levels in striatal microdialysates of parkinsonian rats.

Authors:  Przemysław Nowak; Rose Anna Kostrzewa; Dariusz Skaba; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2009-09-04       Impact factor: 3.911

2.  A vital role for voltage-dependent potassium channels in dopamine transporter-mediated 6-hydroxydopamine neurotoxicity.

Authors:  P T Redman; B S Jefferson; C B Ziegler; O V Mortensen; G E Torres; E S Levitan; E Aizenman
Journal:  Neuroscience       Date:  2006-10-04       Impact factor: 3.590

3.  Response of mitochondrial antioxidant system and respiratory pathways to reactive nitrogen species in pea leaves.

Authors:  María C Martí; Igor Florez-Sarasa; Daymi Camejo; Beatriz Pallol; Ana Ortiz; Miquel Ribas-Carbó; Ana Jiménez; Francisca Sevilla
Journal:  Physiol Plant       Date:  2012-06-27       Impact factor: 4.500

4.  Stable expression of short interfering RNA for DT-diaphorase induces neurotoxicity.

Authors:  Jorge Lozano; Patricia Muñoz; Beston F Nore; Susan Ledoux; Juan Segura-Aguilar
Journal:  Chem Res Toxicol       Date:  2010-09-20       Impact factor: 3.739

5.  Protective effects of nicotine against aminochrome-induced toxicity in substantia nigra derived cells: implications for Parkinson's disease.

Authors:  Patricia Muñoz; Sandro Huenchuguala; Irmgard Paris; Carlos Cuevas; Monica Villa; Pablo Caviedes; Juan Segura-Aguilar; Yousef Tizabi
Journal:  Neurotox Res       Date:  2012-04-12       Impact factor: 3.911

6.  6-hydroxydopamine does not reduce molecular oxygen directly, but requires a coreductant.

Authors:  P Gee; A J Davison
Journal:  Arch Biochem Biophys       Date:  1984-05-15       Impact factor: 4.013

7.  6-Hydroxydopamine: evidence for superoxide radical as an oxidative intermediate.

Authors:  R E Heikkila; G Cohen
Journal:  Science       Date:  1973-08-03       Impact factor: 47.728

8.  Separation and characterization of isoforms of DT-diaphorase from rat liver cytosol.

Authors:  J Segura-Aguilar; R Kaiser; C Lind
Journal:  Biochim Biophys Acta       Date:  1992-03-27

9.  Inhibition of VMAT-2 and DT-diaphorase induce cell death in a substantia nigra-derived cell line--an experimental cell model for dopamine toxicity studies.

Authors:  Patricio Fuentes; Irmgard Paris; Melissa Nassif; Pablo Caviedes; Juan Segura-Aguilar
Journal:  Chem Res Toxicol       Date:  2007-04-11       Impact factor: 3.739

10.  Molecular and neurochemical mechanisms in PD pathogenesis.

Authors:  Irmgard Paris; Jorge Lozano; Carolina Perez-Pastene; Patricia Muñoz; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2009-05-20       Impact factor: 3.911

View more
  6 in total

1.  Neurotoxin mechanisms and processes relevant to Parkinson's disease: an update.

Authors:  Juan Segura-Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2015-01-29       Impact factor: 3.911

Review 2.  Impact of Plant-Derived Flavonoids on Neurodegenerative Diseases.

Authors:  Silvia Lima Costa; Victor Diogenes Amaral Silva; Cleide Dos Santos Souza; Cleonice Creusa Santos; Irmgard Paris; Patricia Muñoz; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2016-03-07       Impact factor: 3.911

3.  6-Hydroxydopamine: a far from simple neurotoxin.

Authors:  Damir Varešlija; Keith F Tipton; Gavin P Davey; Andrew G McDonald
Journal:  J Neural Transm (Vienna)       Date:  2020-01-01       Impact factor: 3.575

4.  Protective mechanism of Syringic acid in an experimental model of Parkinson's disease.

Authors:  Özge Güzelad; Ayşe Özkan; Hande Parlak; Osman Sinen; Ebru Afşar; Eren Öğüt; Fatoş Belgin Yıldırım; Mehmet Bülbül; Aysel Ağar; Mutay Aslan
Journal:  Metab Brain Dis       Date:  2021-03-05       Impact factor: 3.584

Review 5.  Toxin-Induced Experimental Models of Learning and Memory Impairment.

Authors:  Sandeep Vasant More; Hemant Kumar; Duk-Yeon Cho; Yo-Sep Yun; Dong-Kug Choi
Journal:  Int J Mol Sci       Date:  2016-09-01       Impact factor: 5.923

6.  Neuroprotective Activity of Some Marine Fungal Metabolites in the 6-Hydroxydopamin- and Paraquat-Induced Parkinson's Disease Models.

Authors:  Ekaterina A Yurchenko; Ekaterina S Menchinskaya; Evgeny A Pislyagin; Phan Thi Hoai Trinh; Elena V Ivanets; Olga F Smetanina; Anton N Yurchenko
Journal:  Mar Drugs       Date:  2018-11-21       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.